デフォルト表紙
市場調査レポート
商品コード
1701098

組織切片作製の市場規模、シェア、成長分析:製品別、技術別、材料タイプ別、用途別、最終用途別、地域別 - 産業予測 2025~2032年

Tissue Sectioning Market Size, Share, and Growth Analysis, By Product (Instruments, Accessories & Consumables), By Technology (Automatic, Semiautomatic), By Material Type, By Application, By End-Use, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
組織切片作製の市場規模、シェア、成長分析:製品別、技術別、材料タイプ別、用途別、最終用途別、地域別 - 産業予測 2025~2032年
出版日: 2025年04月02日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

組織切片作製の世界市場規模は2023年に5億9,486万米ドルとなり、予測期間(2025~2032年)のCAGRは10.8%で、2024年の6億5,910万米ドルから2032年には14億9,718万米ドルに成長する見通しです。

組織切片作製市場はヘルスケアとライフサイエンスにとって極めて重要であり、研究、診断、治療戦略の進歩を促進します。主な動向は、がんや神経疾患などの慢性疾患の罹患率上昇に後押しされ、堅調な成長を示しています。組織切片作製は、薄い組織サンプルの詳細な検査を可能にし、病気の進行の理解や治療効果の評価に不可欠な病理組織学や分子生物学のアプリケーションをサポートします。特に自動化されたハイスループット・システムにおける技術革新は、精度と効率を高め、潜在的な診断ミスを最小限に抑えています。さらに、個別化医療や精密診断の需要が高まるにつれて、精密な組織分析の重要性が高まり、オーダーメイドの治療計画を策定し、患者の治療成績を向上させる上で、組織切片作製が不可欠な役割を担っています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制情勢
  • 特許分析

組織切片作製市場規模:製品別

  • 市場概要
  • 機器
    • 回転式ミクロトーム
    • スライディングミクロトーム
    • ウルトラミクロトーム
    • クライオスタット
    • その他
  • アクセサリーと消耗品
  • サービス

組織切片作製市場規模:技術別

  • 市場概要
  • 自動
  • 半自動
  • 手動

組織切片作製市場規模:材料タイプ別

  • 市場概要
  • パラホルムアルデヒド
  • OCTコンパウンド
  • ホルマリン
  • 包埋媒体

組織切片作製市場規模:用途別

  • 市場概要
  • 診断
  • 調査

組織切片作製市場規模:最終用途別

  • 市場概要
  • 病院
  • クリニック
  • 診断検査室
  • 研究センター

組織切片作製市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022~2024年)

主要企業プロファイル

  • Thermo Fisher Scientific Inc.(USA)
  • Leica Biosystems(USA)
  • Sakura Finetek USA, Inc.(USA)
  • Agilent Technologies, Inc.(USA)
  • Merck KGaA(Germany)
  • Roche Diagnostics(Switzerland)
  • CellPath Ltd(UK)
  • Gilson Incorporated(USA)
  • RMC Boeckeler(USA)
  • SLEE medical GmbH(Germany)
  • MEDITE GmbH(Germany)
  • Jinhua YIDI Medical Appliance Co., Ltd.(China)
  • Diapath S.p.A.(Italy)
  • Hacker Instruments & Industries Inc.(USA)
  • Bright Instrument Company td(UK)
  • Boeckel+Co(GmbH+Co)KG(Germany)
  • MICROS Produktions-und Handelsgesellschaft m.b.H(Austria)
  • Nanolytik GmbH(Germany)
  • Microservice S.r.l.(Italy)
  • Screen Holdings Co., Ltd.(Japan)

結論と提言

目次
Product Code: SQMIG35H2243

Global Tissue Sectioning Market size was valued at USD 594.86 million in 2023 and is poised to grow from USD 659.1 million in 2024 to USD 1497.18 million by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

The Tissue Sectioning Market is crucial to healthcare and life sciences, driving advancements in research, diagnostics, and treatment strategies. Key trends indicate robust growth, primarily fueled by the rising incidence of chronic diseases, including cancer and neurological disorders. Tissue sectioning enables detailed examination of thin tissue samples, supporting applications in histopathology and molecular biology, vital for understanding disease progression and evaluating treatment efficacy. Technological innovations, particularly in automated and high-throughput systems, are enhancing accuracy and efficiency, minimizing potential diagnostic errors. Moreover, as the demand for personalized medicine and precision diagnostics grows, the importance of precise tissue analysis escalates, solidifying tissue sectioning's integral role in developing tailored treatment plans and improving patient care outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Sectioning market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Sectioning Market Segments Analysis

Global Tissue Sectioning Market is segmented by Product, Technology, Material Type, Application, End-Use and region. Based on Product, the market is segmented into Instruments, Accessories & Consumables and Services. Based on Technology, the market is segmented into Automatic, Semiautomatic and Manual. Based on Material Type, the market is segmented into Paraformaldehyde, OCT Compound, Formalin and Embedding Media. Based on Application, the market is segmented into Diagnosis and Research. Based on End-Use, the market is segmented into Hospitals, Clinics, Diagnostic Laboratories and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Sectioning Market

The increasing incidence of chronic illnesses, including cancer, cardiovascular diseases, and neurological disorders, has emerged as a major catalyst for the growth of the global tissue sectioning market. This essential technique in pathology and research plays a vital role in the diagnosis and comprehension of these medical conditions. With an aging global population and a corresponding rise in the prevalence of chronic diseases, there is a surging demand for tissue sectioning tools and services. Consequently, the tissue sectioning market is experiencing substantial growth, driven by the urgent need for precise diagnostic methods to address these health challenges.

Restraints in the Global Tissue Sectioning Market

The Global Tissue Sectioning market faces notable constraints primarily due to the high costs associated with advanced automated tissue sectioning equipment. This financial burden can deter smaller laboratories, clinics, and research institutions that operate on tight budgets from investing in such technology. The substantial initial expenses related to both the purchase and maintenance of these advanced systems can obstruct their widespread adoption, particularly in environments with limited financial resources. Consequently, the financial barriers presented by the pricing of tissue sectioning equipment may hinder technological advancements and limit access to quality tissue sectioning solutions in various healthcare and research settings.

Market Trends of the Global Tissue Sectioning Market

The Global Tissue Sectioning market is witnessing a transformative shift driven by the automation and digitization of tissue sectioning processes. Automated equipment, including advanced microtomes and cryostats, significantly enhances workflow efficiency and precision, thereby minimizing cross-contamination risks. This increase in automation is complemented by a notable trend towards digitizing tissue samples, fostering improved storage, analysis, and interoperability among pathology laboratories. The rise of digital pathology systems, integrated with sophisticated image analysis software, is making it easier for researchers and clinicians to access and interpret tissue data, ultimately propelling advancements in diagnostics and personalized medicine within a fast-evolving marketplace.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Patent Analysis

Global Tissue Sectioning Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Instruments
    • Rotary Microtome
    • Sliding Microtome
    • Ultramicrotome
    • Cryostat
    • Others
  • Accessories & Consumables
  • Services

Global Tissue Sectioning Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Automatic
  • Semiautomatic
  • Manual

Global Tissue Sectioning Market Size by Material Type & CAGR (2025-2032)

  • Market Overview
  • Paraformaldehyde
  • OCT Compound
  • Formalin
  • Embedding Media

Global Tissue Sectioning Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Diagnosis
  • Research

Global Tissue Sectioning Market Size by End-Use & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Research Centers

Global Tissue Sectioning Market Size & CAGR (2025-2032)

  • North America (Product, Technology, Material Type, Application, End-Use)
    • US
    • Canada
  • Europe (Product, Technology, Material Type, Application, End-Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Technology, Material Type, Application, End-Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Technology, Material Type, Application, End-Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Technology, Material Type, Application, End-Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Leica Biosystems (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sakura Finetek USA, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CellPath Ltd (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gilson Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RMC Boeckeler (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SLEE medical GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEDITE GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jinhua YIDI Medical Appliance Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diapath S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hacker Instruments & Industries Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bright Instrument Company td (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boeckel + Co (GmbH + Co) KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MICROS Produktions- und Handelsgesellschaft m.b.H (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nanolytik GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microservice S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Screen Holdings Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations